Both in Pharmaceuticals
Entrada Therapeutics vs Niagen Bioscience
Over the past year TRDA returned −30.4% and NAGE returned −67.4%; their daily moves had a correlation of 0.43.
TRDA −30.4% NAGE −67.4%Growth of $1, one year, split-adjusted
| Metric | TRDA | NAGE |
|---|---|---|
| Price | $4.72 | $2.36 |
| Market cap | $183.8M | $186.7M |
| Today | −7.63% | −1.67% |
| 1 month | −13.9% | −11.9% |
| 6 months | −70.0% | −51.0% |
| Year to date | −54.1% | −62.9% |
| 1 year | −32.1% | −68.7% |
| Revenue growth (YoY) | −53.9% | −4.3% |
| Gross margin | 100.0% | 64.8% |
| Net margin | −4762.0% | 3.2% |
| P/E (TTM) | — | 11.7× |
| Price / sales | 39.2× | 1.4× |
| Net cash | $223.0M | $66.7M |
| Dividend yield | — | — |
| Volatility (60d) | 84.9% | 37.2% |
| Short % of float | 13.0% | 8.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).